What Happened?
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) jumped 11% in the afternoon session after the company reported second-quarter 2026 results that surpassed Wall Street's expectations for both revenue and profit.
The company posted revenue of $5.30 billion, up 5.8% year-over-year, and an adjusted profit of $1.13 per share, beating consensus estimates by 0.5% and 9.1%, respectively. Management also reaffirmed its full-year earnings guidance, which analysts noted was slightly ahead of expectations.
Another positive sign was the improvement in free cash flow, which clocked in at $68 million, a significant increase from the same quarter last year. The strong quarterly performance, highlighted by the earnings beat, appeared to boost investor confidence.
Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
GE HealthCare’s shares are not very volatile and have only had 4 moves greater than 5% over the last year. Moves this big are rare for GE HealthCare and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock dropped 6.5% on the news that the company reported second-quarter results that revealed significant pressure on its profit margins, overshadowing an increase in its full-year guidance. While GE HealthCare raised its full-year guidance and reported a 3% increase in revenue, investors honed in on signs of declining profitability. The company's adjusted EBIT margin, a key measure of operational profit, contracted to 14.6% from 15.3% in the prior year. This squeeze was attributed to the impact of tariffs, which productivity gains could not fully offset. The weakness was pronounced in major segments, as the Imaging division's EBIT fell by 10% and the Patient Care Solutions segment saw a significant 23% drop in EBIT. The market's negative reaction suggested these margin pressures overshadowed the company's otherwise positive outlook.
GE HealthCare is down 14.1% since the beginning of the year, and at $71.16 per share, it is trading 19.3% below its 52-week high of $88.16 from January 2026.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.